MiR-889 promotes proliferation of esophageal squamous cell carcinomas through DAB2IP

FEBS Letters

Volumn 589, Issue 10, 2015, Pages 1127-1135

  Xu, Yanting ^a   He, Jiangtu ^a   Wang, Yue ^a   Zhu, Xinyi ^a   Pan, Qiuhui ^a   Xie, Qiuling ^b   Sun, Fenyong ^a  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

Cell proliferation; DAB2IP; Esophageal squamous cell carcinoma; miR 889

Indexed keywords

DAB2IP PROTEIN, HUMAN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MICRORNA; RNA; TUMOR MARKER; TUMOR PROTEIN;

BIOSYNTHESIS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION; GENETICS; HELA CELL LINE; HUMAN; METABOLISM; PATHOLOGY;

CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MICRORNAS; NEOPLASM PROTEINS; RAS GTPASE-ACTIVATING PROTEINS; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 84933511791     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2015.03.027     Document Type: Article

References (32)

1. L. Xing Definitive chemoradiotherapy with capecitabine and cisplatin for elder patients with locally advanced squamous cell esophageal cancer J. Cancer Res. Clin. Oncol. 140 2014 867 872
2. N. Wang MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma Dig. Dis. Sci. 58 2013 1863 1870
3. M. Quintavalle MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro J. Cell Biol. 189 2010 13 22
4. X. Dang MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells Cancer Genet. 205 2012 113 123
5. M. Inui MicroRNA control of signal transduction Nat. Rev. Mol. Cell Biol. 11 2010 252 263
6. K.R. Cordes MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity Nature 460 2009 705 710
7. X. Xu MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma Biochem. Biophys. Res. Commun. 421 2012 640 645
8. Y. Qi Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection BMC Infect. Dis. 12 2012 384
9. S. Molina-Pinelo MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer BMC Cancer 14 2014 656
10. M. Smits EZH2-regulated DAB2IP is a medulloblastoma tumor suppressor and a positive marker for survival Clin. Cancer Res. 18 2012 4048 4058
11. K. Wu The role of DAB2IP in androgen receptor activation during prostate cancer progression Oncogene 33 2014 1954 1963
12. X. Dai Negative regulation of DAB2IP by Akt and SCFFbw7 pathways Oncotarget 5 2014 3307 3315
13. D. Xie DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis Proc. Natl. Acad. Sci. USA 106 2009 19878 19883
14. D. Xie Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis Proc. Natl. Acad. Sci. USA 107 2010 2485 2490
15. K. Wu The mechanism of DAB2IP in chemoresistance of prostate cancer cells Clin. Cancer Res. 19 2013 4740 4749
16. Z. Kong Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation Cancer Res. 70 2010 2829 2839
17. Y.J. Shen Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer Cancer Sci. 105 2014 704 712
18. X. Zhang Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma J. Gastroenterol. Hepatol. 27 2012 1117 1125
19. L. Yang A common genetic variant (97906C>A) of DAB2IP/AIP1 is associated with an increased risk and early onset of lung cancer in Chinese males PLoS One 6 2011 e26944
20. Y.-F. Duan Decreased expression of DAB2IP in pancreatic cancer with wild-type KRAS Hepatobiliary Pancreat. Dis. Int. 12 2013 204 209
21. H. Chen Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer J. Biol. Chem. 280 2005 22437 22444
22. X. Yuan Effects and interactions of MiR-577 and TSGA10 in regulating esophageal squamous cell carcinoma Int. J. Clin. Exp. Pathol. 6 2013 2651 2667
23. Q. Yang NRAGE promotes cell proliferation by stabilizing PCNA in a ubiquitin-proteasome pathway in esophageal carcinomas Carcinogenesis 35 2014 1643 1651
24. L. Zhang Effects of cyclooxygenase-2 on human esophageal squamous cell carcinoma World J. Gastroenterol. 17 2011 4572 4580
25. J. Ma Depletion of intermediate filament protein Nestin, a target of microRNA-940, suppresses tumorigenesis by inducing spontaneous DNA damage accumulation in human nasopharyngeal carcinoma Cell Death Dis. 5 2014 e1377
26. R. Zhang AIP1 mediates TNF-alpha-induced ASK1 activation by facilitating dissociation of ASK1 from its inhibitor 14-3-3 J. Clin. Invest. 111 2003 1933 1943
27. Z. Wang The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2 J. Biol. Chem. 277 2002 12622 12631
28. J.A. Ewald Expression microarray meta-analysis identifies genes associated with Ras/MAPK and related pathways in progression of muscle-invasive bladder transition cell carcinoma PLoS One 8 2013 e55414
29. E.J. Yun DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor receptor and ZEB1 Oncogene 2014
30. X.X. He The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma Mol. Biosyst. 2014 10.1039/c1034mb00563e in press
31. N. Tanimizu Downregulation of miR122 by grainyhead-like 2 restricts the hepatocytic differentiation potential of adult liver progenitor cells Development 141 2014 4448 4456
32. Y. Tian MicroRNA-200 cluster regulation by Ascl 2: impact on the epithelial-mesenchymal transition in colon cancer cells J. Biol. Chem. 2014 10.1074/jbc.M1114.598383 in press